Cardiome Pharma Corp. (USA) (NASDAQ:CRME)

CAPS Rating: 3 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Recs

0
Player Avatar downyesterday (< 20) Submitted: 10/14/2009 9:49:05 PM : Outperform Start Price: $4.48 CRME Score: -111.62

Pick up on a drop

Featured Broker Partners


Advertisement